Evidence map›Paper›PMID 36655425›Full record

ArticleHaematologica2023

Clinical and molecular response of acute myeloid leukemia harboring non-canonical

Gregory W Roloff, Frank Wen, Aubrianna Ramsland, Andrew S Artz, Satyajit Kosuri, Wendy Stock, Olatoyosi Odenike, Richard A Larson, Hongtao Liu, Lucy A Godley and 12 more

Abstract readLetter
In one paragraph

Article in Haematologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Gregory W RoloffSection of Hematology/Oncology, The University of Chicago.
Frank WenSection of Hematology/Oncology, The University of Chicago.
Aubrianna RamslandSection of Hematology/Oncology, The University of Chicago.
Andrew S ArtzDivision of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte CA.
Satyajit KosuriSection of Hematology/Oncology, The University of Chicago.
Wendy StockSection of Hematology/Oncology, The University of Chicago.
Olatoyosi OdenikeSection of Hematology/Oncology, The University of Chicago.
Richard A LarsonSection of Hematology/Oncology, The University of Chicago.
Hongtao LiuSection of Hematology/Oncology, The University of Chicago.
Lucy A GodleySection of Hematology/Oncology, The University of Chicago.
Michael J ThirmanSection of Hematology/Oncology, The University of Chicago.
Anand A PatelSection of Hematology/Oncology, The University of Chicago.
Christopher K DaughertySection of Hematology/Oncology, The University of Chicago.
Adam S DuVallSection of Hematology/Oncology, The University of Chicago.
Mariam T NawasSection of Hematology/Oncology, The University of Chicago.
Emily DworkinSection of Hematology/Oncology, The University of Chicago.
Geoffrey D WoolDepartment of Pathology, The University of Chicago.
Sandeep GurbuxaniDepartment of Pathology, The University of Chicago.
Carrie FitzpatrickDepartment of Pathology, The University of Chicago.
Jeremy P SegalDepartment of Pathology, The University of Chicago.
Peng WangDepartment of Pathology, The University of Chicago.
Michael W DrazerSection of Hematology/Oncology, The University of Chicago. mdrazer@medicine.bsd.uchicago.edu.

Funding

BASIC RESEARCH TRAINING IN MEDICAL ONCOLOGYT32CA009566 · NCI · UNIVERSITY OF CHICAGO · PI OLUFUNMILAYO F. OLOPADE · 1987 to 2026
$10.5M
NCI NIH HHS L30 CA285176NCI NIH HHS T32 CA009566
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Myeloid, Acutefms-Like Tyrosine Kinase 3HumansMutationProtein Kinase InhibitorsFLT3 protein, humanfms-Like Tyrosine Kinase 3Protein Kinase Inhibitors

Identifiers

PMID36655425
PMCPMC10388285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.